Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genetic Testing of Noonan Subjects Previously Treated With Norditropin® in the GHNOO-1658 Trial

NCT01529944 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01529944
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01529944 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genetic Testing of Noonan Subjects Previously Treated With Norditropin® in the GHNOO-1658 Trial
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2008
Completion date
October 31, 2008
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genetic disorder, noonan syndrome